Resveratrol's relationship with oestrogen is one of the most nuanced — and most misunderstood — topics in sports supplementation. Concerns about resveratrol acting as a "phytoestrogen" and causing unwanted hormonal effects, water retention, or body composition changes circulate widely in fitness communities. This article examines what the science actually shows.
Resveratrol as a Selective Estrogen Receptor Modulator (SERM)
Resveratrol binds to both oestrogen receptor alpha (ERα) and beta (ERβ), but with differential effects depending on the receptor type and tissue. This places it in the category of selective oestrogen receptor modulators (SERMs) — the same pharmacological class as tamoxifen and raloxifene, though with far weaker binding affinity (approximately 7000-10,000x weaker than oestradiol).
In tissues where ERβ predominates (bone, cardiovascular, brain), resveratrol has broadly oestrogenic effects — beneficial for bone density, cardiovascular function, and neuroprotection. In tissues where ERα predominates (breast tissue, uterus), resveratrol tends to act as an oestrogen antagonist, blocking stronger oestrogenic signals. This is why resveratrol has been studied as a potential cancer-protective agent in hormone-sensitive cancers.
Water Retention: Does Resveratrol Cause It?
Oestrogen (particularly oestradiol) promotes water retention by upregulating aldosterone and increasing sodium reabsorption in the kidneys. The concern is that resveratrol's oestrogenic activity could do the same. The evidence does not support this at supplemental doses. Multiple clinical trials using 150-500mg resveratrol daily have not reported water retention as an adverse effect, and no mechanistic data suggests resveratrol's weak ERα activity is sufficient to trigger meaningful aldosterone changes.
In contrast, resveratrol's AMPK activation and improved insulin sensitivity tend to improve body composition by reducing fat accumulation — the opposite of what oestrogen-driven water retention would suggest.
Body Composition Effects
The evidence on resveratrol and body composition is largely positive. In obese men and women, resveratrol supplementation has been associated with reductions in visceral fat and improved insulin sensitivity. The SIRT1 activation pathway promotes fat mobilisation from adipose tissue and mitochondrial biogenesis — both favourable for body composition.
In healthy lean individuals, resveratrol's body composition effects are more modest. No studies show meaningful fat gain or water retention at doses up to 1000mg/day.
Practical Guidance
For both men and women at standard supplemental doses (150-500mg trans-resveratrol daily): no meaningful hormonal disruption, no evidence of water retention, and potentially positive body composition effects through metabolic pathways. Men with concerns about oestrogenic activity can take comfort in resveratrol's antagonistic effects at ERα in many tissues. Women in perimenopause or post-menopause may actually benefit from resveratrol's mild oestrogenic activity on bone and cardiovascular tissue.
